Anthony D Souza MD in Sarasota, Florida

Medical School: Sorry, his university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Anthony D Souza MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 9537061130
NPI #: 1073560736
NPI Created On: 05/28/2006
NPI Last Updated Listed as: 01/20/2022
Primary Taxonomy Code: 207UN0901X
License Number:
023268
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Subsequent hospital inpatient care, typically 25 minutes per day
14. Physician telephone patient service, 11-20 minutes of medical discussion
15. Physician telephone patient service, 21-30 minutes of medical discussion
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg